Skip to main content

COVID 19 Updates from RheumNow

RheumNow Podcast – Mistakes with Steroids

Dr Jack Cush gives his spin on this week's RheumNews and Rheum Research from RheumNow.com.

Rheumatology Care Derailed by COVID-19

A survey study from the  ArthritisPower PPRN or CreakyJoints database shows that during the COVID-19 pandemic patient care was substantially affected in unforeseen ways.

Reactogenicity Following mRNA COVID-19 Vaccines

JAMA has published the real-world reporting of mRNA vaccine side effects (reactogenicity) gathered from CDC V-safe Surveillance system and shows that local and systemic reactions were often mild and transient and most commonly seen during the first day following their second dose.

RheumNow Podcast – Great Associations (3.19.2021)

Dr. Jack Cush rants on the journal reports, news and FDA actions featured this past week on RheumNow.com.

Rheumatic Patients Are at Risk for COVID Death

MedPage Today

Patients with rheumatic diseases who developed COVID-19 were at increased likelihood of death, with risk factors similar to those seen in the general population but also because of factors specific to their underlying disease and its treatment, analysis of data from an international registry foun

Rebuttals

Since the COVID vaccine rollout, more people have been eligible to receive the vaccine. However, not everyone chooses to get one. I have heard many reasons (aka excuses) from my patients who are vaccine hesitant. 

RheumNow Podcast – Listener Questions (3.12.2021)

Dr Jack Cush reviews the news, Journal reports, CDC guidelines and viewer questions from the last week on RheumNow.com

Low Anaphylaxis Risk with COVID mRNA Vaccines

JAMA reports a safety survey of hospital employees showing that the risk of anaphylaxis from mRNA vaccines is 2.47 per 10,000 individuals. 

COVID-19-Related Deaths in Rheumatic Disease Patients

There is a growing body of evidence regarding COVID-19 outcomes (including death) in rheumatic disease patients; analysis of a German registry shows that poor control, rituximab, sulfasalazine and other immunosuppressives could be risk factors for COVID-related death.

CDC: Interim Guidance for COVID Vaccinated People

Among 330 million Americans, roughly 32.1 million have been fully vaccinated and 61.1 million have received at least one dose of a COVID-19 vaccine (as of March 8th).

RheumNow Podcast – Pounds of Prevention (3.5.2021)

Dr. Jack Cush reviews nearly a dozen news reports and journal articles from the past week on RheumNow.com.

Social

Survey of 500 pts with systemic rheumatic diseases during the COVID-19 pandemic showed few who discontinuations Rx - 2.2% D/C for fear of immunosuppression; 3.8% for shortages (mostly HCQ); 2.6%) for resp infx and 6% for side-effects. https://t.co/2BJIYeBSIu

Dr. John Cush @RheumNow ( View Tweet )

2 weeks 5 days ago
Hydroxychloroquine studied vs Vitamin C (PBO) prophylaxis to households (n=671) exposed to COVID-19. 89% were COVD1-9 test neg at baseline. HCQ did not protect against progression to COVID (53 vs 45 events; adj HR, 1.10 [95% CI, 0.73 to 1.66]. A vit C Win! https://t.co/S5qjdIYaXq

Dr. John Cush @RheumNow ( View Tweet )

3 weeks 3 days ago
News Feature: Comparison of Three Coronavirus Vaccines https://t.co/omxsA8W3nQ https://t.co/s7dc9NwMQo
Dr. John Cush @RheumNow ( View Tweet )
3 weeks 4 days ago
News Feature: Rheumatic Patients Are at Risk for COVID Death https://t.co/bhJG1vuVA4 https://t.co/VEN3nwSOPB
Dr. John Cush @RheumNow ( View Tweet )
3 weeks 4 days ago
REMDACTA trial of Actemra plus remdesivir failed to meet its primary endpoint of improved time to hospital discharge for patients with severe COVID-19 pneumonia (nor its key secondary endpoints) compared to remdesivir alone https://t.co/OyqpnwUVXU

Dr. John Cush @RheumNow ( View Tweet )

3 weeks 4 days ago
News Feature: Low Anaphylaxis Risk with COVID mRNA Vaccines JAMA reports a safety survey of hospital employees showing that the risk of anaphylaxis from mRNA vaccines is 2.47 per 10,000 individuals. https://t.co/hN7UWNasQo https://t.co/0UhOZuGze1
Dr. John Cush @RheumNow ( View Tweet )
3 weeks 5 days ago
COVID Vaccine Rebuttals by Dr. Kathryn Dao ( @KDAO2011) Dr. Dao addresses the common vaccine concerns that have been posed to her and her rebuttals. https://t.co/f5gwBICEGy https://t.co/Nzm1HfY5GW
Dr. John Cush @RheumNow ( View Tweet )
3 weeks 5 days ago
News Feature: Low Anaphylaxis Risk with COVID mRNA Vaccines JAMA reports a safety survey of hospital employees showing that the risk of anaphylaxis from mRNA vaccines is 2.47 per 10,000 individuals. https://t.co/hN7UWNasQo https://t.co/pVlaTUSCH7
Dr. John Cush @RheumNow ( View Tweet )
4 weeks 1 day ago
News Feature: COVID-19-Related Deaths in Rheumatic Disease Patients There is a growing body of evidence regarding COVID-19 outcomes (including death) in rheumatic disease patients... https://t.co/N3SGTnTjsq https://t.co/Xlnt3oxKbo
Dr. John Cush @RheumNow ( View Tweet )
4 weeks 2 days ago
News Feature: CDC: Interim Guidance for COVID Vaccinated People https://t.co/3GZDCVF0hv https://t.co/qyQyajjqM8
Dr. John Cush @RheumNow ( View Tweet )
1 month ago
×